[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 2 sources · 25 days · First seen · Last updated

Oncosem capital increase process

Overview

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş. announced plans for a 1,200% bonus capital increase, aiming to raise its issued share capital from 23.85 million Turkish lira (TL) to 310.05 million TL.

The increase is to be funded entirely through internal resources, specifically utilizing emission premiums, equity-inflation adjustment differences, and other profit reserves. To facilitate this transaction, the company intends to utilize a one-time allowance to exceed its current registered capital ceiling of 99 million TL.

Following the initial board decision in July 2026, the company officially applied to the Capital Markets Board (SPK) for approval on August 8, 2026. New shares will be distributed proportionally to existing Group A and Group B shareholders once regulatory approval is granted.

Entities

Capital Markets Board of Turkey · Public Disclosure Platform · Oncosem Onkolojik Sistemler Sanayi ve Ticaret A. Ş.

Timeline

  1. 8 days ago

    [BUSINESS] 2 sources
    Oncosem applies for 1200% bonus capital increase

    Oncosem (ONCSM) has applied to the Capital Markets Board for a 1200% bonus capital increase, raising its capital from 23.85 million TL to 310.05 million TL using internal resources.

  2. about 1 month ago

    [BUSINESS] 3 sources
    Oncosem Boosts Capital by 1200% to 310.05 million TL in Free Share Issue

    Oncosem announced a 1200% bonus capital increase, raising issued capital from 23.85 M TL to 310.05 M TL using internal reserves, pending SPK approval.

Sources

dartsnmore.com · ekz.ch